Quarterly report pursuant to Section 13 or 15(d)

Equity

v3.23.2
Equity
 6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Equity

Note 5 - Equity 

 

In August 2020, the Company entered into the Capital on Demand™ Sales Agreement with JonesTrading Institutional Services LLC, or JonesTrading, pursuant to which the Company may sell, from time to time, through or to JonesTrading, up to an aggregate of $200 million of its common stock. Shares of common stock are offered pursuant to a shelf registration statement on Form S-3 filed with the SEC on August 7, 2020. On June 28, 2022, the Company entered into an Amended and Restated Capital on Demand™ Sales Agreement (the “A&R Sales Agreement”) with JonesTrading and B. Riley Securities, Inc. (“B. Riley Securities”). The A&R Sales Agreement modifies the original Capital on Demand™ Sales Agreement to include B. Riley Securities as an additional sales agent thereunder.

 

For the six months ended June 30, 2023, the Company sold 1.3 million shares of common stock, resulting in gross proceeds of $10.9 million and net proceeds of $10.6 million. For the six months ended June 30, 2022, the Company sold 2.7 million shares of common stock, resulting in gross proceeds of $17.2 million and net proceeds of $16.7 million.

 

Stock Options

 

The following is a summary of stock option activity for the six months ended June 30, 2023:

 

(in thousands, except for per-share amounts)   Number
of Shares		     Weighted
Average
Exercise
Price ($)		     Weighted
Average
Remaining
Contractual
Term
(in years)		     Aggregate
Intrinsic
Value		  
Outstanding, January 1, 2023     3,396     $ 8.00       8.85     $ 15,204  
Granted     151       8.85                  
Exercised     (44 )     5.92                  
Cancelled     (85 )     5.76                  
Outstanding, June 30, 2023     3,418       8.12       8.42       5,293  
                                 
Exercisable, June 30, 2023     1,126       12.61       7.50       1,306  

 

During the six months ended June 30, 2023, the Company granted stock options to new employees to purchase 151 thousand shares of common stock with an exercise price ranging from $8.05 to $11.60 per share, a term of 10 years, and a vesting period of 4 years. The options have an aggregated fair value of $1.0 million that was calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate range from 3.5% to 4.21% (2) expected life of 6 years, (3) expected volatility range from 81.1% to 81.6%, and (4) zero expected dividends.

 

The fair values of all options issued and outstanding are being amortized over their respective vesting periods. The unrecognized compensation expense at June 30, 2023 was $9.0 million related to unvested options, which is expected to be expensed over a weighted average of 3.0 years. During the six months ended June 30, 2023 and 2022, the Company recorded compensation expense related to stock options of $1.7 million and $0.8 million, respectively.

 

Restricted Stock Units

 

The following is a summary of restricted stock unit, or RSU, activity for the six months ended June 30, 2023:

 

(in thousands, except for per-share amount)   RSUs     Weighted
Average
Grant date Fair Value
Per Share ($)		  
Outstanding, January 1, 2023     325       5.96  
Granted     5       8.31  
Vested    
-
      
-
  
Outstanding, June 30, 2023     330       6.00  

 

The RSUs vest at the earliest of a change of control event, the termination of the recipient’s continuous service status for any reason other than by the Company for cause and the third anniversary of the date of the grant. The fair value of the RSUs, $2.0 million, was determined based on the stock prices on the dates of the grants and each RSU grant is being recognized over its respective three-year period. The unrecognized compensation expense at June 30, 2023 of $1.4 million is expected to be expensed over a weighted average of 2.2 years. During the six months ended June 30, 2023, the Company recorded compensation expense related to RSUs of $0.3 million. There was no compensation expense related to RSUs for the six months ended June 30, 2022.

  

Warrants

 

Following is a summary of warrant activity for the six months ended June 30, 2023:

 

(in thousands, except for per-share amounts)   Number
of Shares		     Weighted
Average
Exercise
Price ($)		     Weighted
Average
Remaining
Contractual
Term
(in years)		     Aggregate
Intrinsic
Value		  
Outstanding, January 1, 2023     1,443     $ 16.58       1.33     $ 5  
Granted     2       8.30       10.00          
Expired    
-
      
-
                  
Outstanding, June 30, 2023     1,445     $ 16.58       0.84     $                -  
                                 
Exercisable, June 30, 2023     1,440     $ 15.94       0.83     $ -